| Typicality: | 0.339 |
| Saliency: | 0.210 |
| at 12 months | 4 | temporal |
| vaccine → be followed by → booster | 9 |
| vaccine → be followed by → a booster dose | 5 |
| negative | neutral | positive |
| 0.067 | 0.821 | 0.112 |
| Raw frequency | 14 |
| Normalized frequency | 0.210 |
| Modifier score | 0.500 |
| Perplexity | 219.125 |